| Literature DB >> 33564865 |
Myrthe van der Bruggen1, Bart Spronck1,2,3, Siske Bos1, Maarten H G Heusinkveld1, Stefano Taddei4, Lorenzo Ghiadoni4, Tammo Delhaas1, Rosa Maria Bruno4,5, Koen D Reesink1.
Abstract
BACKGROUND: Conventional measures for assessing arterial stiffness are inherently pressure dependent. Whereas statistical pressure adjustment is feasible in (larger) populations, it is unsuited for the evaluation of an individual patient. Moreover, statistical "correction" for blood pressure may actually correct for: (i) the acute dependence of arterial stiffness on blood pressure at the time of measurement; and/or (ii) the remodeling effect that blood pressure (hypertension) may have on arterial stiffness, but it cannot distinguish between these processes.Entities:
Keywords: arterial remodeling; arterial stiffness; blood pressure; hypertension; pressure dependence
Mesh:
Year: 2021 PMID: 33564865 PMCID: PMC8351507 DOI: 10.1093/ajh/hpab028
Source DB: PubMed Journal: Am J Hypertens ISSN: 0895-7061 Impact factor: 3.080
Figure 1.At baseline and follow-up, ultrasonic diastolic diameter (Dd), distension, and intima–media thickness (IMT) and oscillometric systolic and diastolic blood pressures (Ps and Pd, respectively) were measured. From the measurements, the changes at follow-up normalized to follow-up time in years (Δ) were calculated for carotid pulse wave velocity (cPWV), Young’s modulus (E), and the recently introduced stiffness index β0 (at reference pressure of 100 mm Hg). Assuming a single-exponential model of the pressure–diameter (P–D) curve, pressure-corrected diastolic diameter and IMT (Dd,corr and IMTcorr), cPWVcorr, and Ecorr were derived. The Δ’s of corrected and conventional measures are subsequently used as dependent variables in linear regression modeling.
Study population characteristics and carotid artery dimensions
| Parameter | Baseline | Follow-up |
|---|---|---|
| Sex (# of m/f) | 83/41 | — |
| Age (years) | 57.7 ± 8.6 | 61.8 ± 9.0** |
| Smoking (number, %) | 24 (19.4%) | 24 (19.4%) |
| Diabetes (number, %) | 35 (28.2%) | 35 (28.2%) |
| Hypercholesterolemia (number, %) | 84 (67.7%) | 63 (67.7%)a |
| Antihypertensive drugs (number, %) | 82 (66.1%) | 109 (87.9)** |
|
| 142 ± 14 | 141 ± 17 |
|
| 82 ± 9 | 79 ± 11** |
| MAP (mm Hg) | 102 ± 9 | 100 ± 11* |
| BMI (kg/m2) | 28.3 ± 4.0 | 28.1 ± 4.2 |
| Heart rate (bpm) | 68 ± 11 | 71 ± 12** |
Data are presented as mean ± SD, n = 124. Abbreviations: BMI, body mass index; Dd, diastolic common carotid diameter; IMT, common carotid intima media thickness (at diastolic pressure); MAP, mean arterial pressure; Pd, diastolic blood pressure; Ps, systolic blood pressure.
a n = 93 due to missing information during follow-up.
Follow-up (2.9 ± 1.0 years) values were tested against baseline values using paired t-tests: *P < 0.05, **P < 0.001.
Conventional and corrected carotid dimensions and stiffness measures
| Parameter | Baseline | Follow-up | Δ (unit/year) |
|---|---|---|---|
| IMT (mm) | 0.75 ± 0.15 | 0.78 ± 0.18 | 0.01 ± 0.08 |
| IMTcorr (mm) | 0.76 ± 0.15 | 0.78 ± 0.18 | 0.01 ± 0.08 |
|
| 7.24 ± 0.85 | 7.55 ± 0.87 | 0.12 ± 0.30** |
|
| 7.20 ± 0.87 | 7.56 ± 0.88 | 0.13 ± 0.30** |
| cPWV (m/s) | 7.5 ± 1.3 | 7.7 ± 1.2 | 0.1 ± 0.6* |
| cPWVcorr (m/s) | 7.1 ± 1.2 | 7.5 ± 1.2 | 0.1 ± 0.6* |
|
| 0.59 ± 0.23 | 0.65 ± 0.23 | 0.02 ± 0.11* |
|
| 0.53 ± 0.20 | 0.61 ± 0.22 | 0.03 ± 0.10** |
|
| 8.5 ± 2.9 | 9.3 ± 2.9 | 0.3 ± 1.3* |
Data are presented as mean ± SD, n = 124. . Abbreviations: β0, pressure-independent stiffness index; cPWV, carotid pulse wave velocity; cPWVcorr, pressure-corrected cPWV; Dd, diastolic diameter; Dd,corr, diameter corresponding to a pressure of 80 mm Hg; E, Young’s modulus; Ecorr, pressure-corrected Young’s modulus; IMT, intima media thickness; IMTcorr, IMT corresponding to a pressure of 80 mm Hg.
Follow-up (2.9 ± 1.0 years) values were tested against baseline values using paired t-tests: *P < 0.05, **P < 0.001.
Final regression models for the associations of ΔcPWV and ΔcPWVcorr, as well as ΔE and ΔEcorr with ΔMAP
| ΔcPWV | ΔcPWVcorr | |||
|---|---|---|---|---|
|
|
|
|
| |
| Crude | 0.023 (0.000; 0.045) | 0.047 | −0.018 (−0.040; 0.003) | 0.091 |
| Model 2 | 0.027 (0.005; 0.050) | 0.019 | −0.018 (−0.039; 0.004) | 0.105 |
| Model 3 | 0.026 (0.002; 0.050) | 0.035 | −0.019 (−0.042; 0.004) | 0.104 |
| Δ | Δ | |||
| Crude | 0.007 (0.003; 0.012) | 0.001 | −0.001 (−0.005; 0.002) | 0.446 |
| Model 2 | 0.007 (0.003; 0.011) | 0.001 | −0.002 (−0.005; 0.002) | 0.398 |
| Model 3 | 0.007 (0.002; 0.012) | 0.003 | −0.002 (−0.006; 0.002) | 0.350 |
Abbreviations: Δ denotes β, unstandardized regression coefficient; BMI, body mass index; CI, 95% confidence interval; cPWV, carotid pulse wave velocity; cPWVcorr, pressure-corrected cPWV according to equation (S1); E, Young’s modulus; Ecorr, pressure-corrected Young’s modulus according to equation (S6); MAP, mean arterial pressure. For ΔcPWV model 2: crude model + ΔIMT, ΔHR, use of antihypertensive drugs at the first visit. Model 3: model 2 + age, sex, smoking status, body mass index, diabetes status, and hypercholesterolemia. For ΔE model 2: crude model + ΔHR and use of antihypertensive drugs at the first visit. Model 3: model 2 + age, sex, smoking status, BMI, diabetes status, and hypercholesterolemia. In models 2 and 3 for ΔcPWV the change in intima–media thickness ΔIMT was used. Correspondingly, in the models for ΔcPWVcorr the pressure-corrected ΔIMTcorr was used.
Final regression models for the association of Δβ0 with ΔMAP
| Δ | ||
|---|---|---|
|
|
| |
| Crude | −0.042 (−0.092; 0.009) | 0.103 |
| Model 2 | −0.040 (−0.090; 0.010) | 0.119 |
| Model 3 | −0.043 (−0.097; 0.011) | 0.119 |
Abbreviations: Δ denotes (follow-up value–baseline value)/(follow-up time in years) β, unstandardized regression coefficient; β0, pressure-independent stiffness index according to equation (4); BMI, body mass index; CI, 95% confidence interval; MAP, mean arterial pressure. Model 2: crude model + corrected ΔIMT, ΔHR, and use of antihypertensive drugs at the first visit. Model 3: model 2 + age, sex, smoking status, BMI, diabetes status, and hypercholesterolemia.